Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele.

Basal cell carcinoma (BCC) of the skin represents a unique group of tumors strongly associated with exposure to UV light. Unlike squamous carcinoma of the skin, BCC is generally indolent, noninvasive, and rarely metastatic. To study the involvement of tumor suppressor genes in these neoplasms, we analyzed 36 BCCs for p53 mutations and a subset of these tumors for loss of chromosomes 17p and 9q. Sixty-nine % of sporadic BCCs had lost a 9q allele, with the common area of loss surrounding the putative gene for nevoid BCC or Gorlin's syndrome. Forty-four % (16 of 36) of BCCs had a mutated p53 allele, usually opposite pyrimidine tracts, which is consistent with UV-induced mutations. Surprisingly, only one tumor had lost a 17p allele, and in all BCCs only one p53 allele was inactivated. This is in direct contrast to other epithelial tumors, which usually progress by the inactivation of both p53 alleles.

[1]  D. Notterman,et al.  The p53 tumor suppressor gene. , 1994, The Journal of laboratory and clinical medicine.

[2]  A. Ziegler,et al.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Levine,et al.  Gain of function mutations in p53 , 1993, Nature Genetics.

[4]  N. Basset-Seguin,et al.  p53 gene mutations in human epithelial skin cancers. , 1993, Oncogene.

[5]  A. Yang,et al.  Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. , 1993, Cancer research.

[6]  L Grossman,et al.  DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Stern,et al.  Nonmelanoma cancers of the skin. , 1992, The New England journal of medicine.

[8]  Leland Hartwell,et al.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells , 1992, Cell.

[9]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[10]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. Scinicariello,et al.  p53 mutations in basal cell carcinomas. , 1992, Cancer research.

[12]  M. Greene,et al.  Developmental defects in gorlin syndrome related to a putative tumor suppressor gene on chromosome 9 , 1992, Cell.

[13]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[14]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Swanson,et al.  Aggressive-growth basal cell carcinoma in young adults. , 1991, Archives of dermatology.

[16]  Stanley J. Miller,et al.  Biology of basal cell carcinoma (Part I). , 1991, Journal of the American Academy of Dermatology.

[17]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[18]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[19]  P. Green,et al.  Identification of p53 gene mutations in bladder cancers and urine samples. , 1991, Science.

[20]  K. Prasad,et al.  Increased production of oxygen free radicals in cigarette smokers. , 1991, International journal of experimental pathology.

[21]  Stanley J. Miller,et al.  Biology of basal cell carcinoma (Part II). , 1991, Journal of the American Academy of Dermatology.

[22]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[23]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[24]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[25]  A. Knudson.  Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[26]  V. Rotter,et al.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene , 1984, Cell.

[27]  G. Jacobs,et al.  Prediction of aggressive behavior in basal cell carcinoma , 1982, Cancer.